Sugi Predict

Sugi Predict / Compounds / SCHEMBL112230

SCHEMBL112230

SCHEMBL112230

Cc1cc(N(CCO)CCO)ccc1/N=N/c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 10/20 0.55
▸ MEN1 O00255 9/20 0.55
▸ MAPT P10636 8/20 0.55
▸ NPC1 O15118 6/20 0.55
▸ RAB9A P51151 6/20 0.55
▸ POLB P06746 5/20 0.55
▸ TDP1 Q9NUW8 4/20 0.55
▸ MAPK1 P28482 3/20 0.55
▸ SMN1; SMN2 Q16637 3/20 0.55
▸ LMNA P02545 2/20 0.55
▸ MMP14 P50281 2/20 0.55
▸ L3MBTL1 Q9Y468 1/20 0.55
▸ ALDH1A1 P00352 6/20 0.52
▸ GAA P10253 2/20 0.52
▸ NPSR1 Q6W5P4 2/20 0.48
▸ HTT P42858 2/20 0.48
▸ TSHR P16473 1/20 0.42
▸ HSP90AA1 P07900 2/20 0.40
▸ RECQL P46063 1/20 0.40
▸ TNNI3 P19429 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29358253 1.00 KMT2A (0.55) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL112231 1.00 KMT2A (0.55) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL10067503 0.95 KMT2A (0.50) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL25419671 0.92 KMT2A (0.47) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL1627083 0.92 KMT2A (0.47) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL7717321 0.91 POLB (0.58) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL1087160 0.91 MAPT (0.52) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL14994403 0.90 KMT2A (0.46) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL30887106 0.90 KMT2A (0.46) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL14994401 0.90 KMT2A (0.46) KMT2AMEN1MAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919439-A2 PROCESS FOR BLEACHING KERATIN FIBERS The Procter and Gamble Company (US) 2008-05-14 — — EP claimed
US-20070231283-A1 Process for bleaching keratin fibers PROCTER & GAMBLE COMPANY, THE 2007-10-04 — — US claimed
WO-2007026327-A2 PROCESS FOR BLEACHING KERATIN FIBERS THE PROCTER & GAMBLE COMPANY (US) 2007-03-08 — — WO claimed
EP-1759684-A1 Process for bleaching keratin fibers Wella Aktiengesellschaft (DE) 2007-03-07 — — EP claimed
EP-1599177-A1 AGENT FOR SIMULTANEOUSLY DYING AND BRIGHTENING KERATIN FIBERS Wella Aktiengesellschaft (DE) 2005-11-30 — — EP claimed
WO-2004078150-A1 AGENT FOR SIMULTANEOUSLY DYING AND BRIGHTENING KERATIN FIBERS WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 — — WO claimed
US-4380769-A SUPPORT WITH AMORPHOUS MATERIAL CONSISTING OF AL DYE AND BINDER EASTMAN KODAK COMPANY (US) 1983-04-19 — — US claimed
EP-3229918-B1 COMPOSITION AND PROCEDURE FOR TREATING KERATINIC FIBERS WITH FLASH EVAPORATION HENKEL AG & CO KGAA (DE) 2024-03-13 — — EP disclosed
US-20230310294-A1 COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS COMPOSITION L'OREAL (FR) 2023-10-05 — — US disclosed
US-20210115489-A1 NOVEL MEDIATOR KIKKOMAN CORPORATION (JP) 2021-04-22 — — US disclosed
EP-2930126-B1 Fashionable aerosol dye HENKEL AG & CO KGAA (DE) 2019-10-09 — — EP disclosed
US-10342751-B2 Double-chamber pouch for dyeing human hair HENKEL AG & CO. KGAA (DE) 2019-07-09 — — US disclosed
US-10259946-B1 Sealing agents, methods of making and uses thereof James Hardie Technology Limited (IE) 2019-04-16 — — US disclosed
EP-0891971-A1 Bispyrazole-aza compounds, processes for their preparation, and hair dyeing agents containing these compounds Wella Aktiengesellschaft (DE) 1999-01-20 — — EP disclosed
EP-0867171-A2 Powder composition for the preparation of gels comprising a methyl hydroxyalkyl cellulose Wella Aktiengesellschaft (DE) 1998-09-30 — — EP disclosed
EP-0118881-B1 BINDER-MIXTURES FOR OPTICAL RECORDING LAYERS AND ELEMENTS EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1988-09-14 — — EP disclosed
US-4626361-A Binder-mixtures for optical recording layers and elements EASTMAN KODAK COMPANY (US) 1986-12-02 — — US disclosed
US-4499165-A COMPATABILITY; STABILITY; LASERS; DATA PROCESSING EASTMAN KODAK COMPANY (US) 1985-02-12 — — US disclosed
EP-0118881-A2 Binder-mixtures for optical recording layers and elements EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1984-09-19 — — EP disclosed
US-4189429-A ANTHRAQUINONE, NAPHTHAQUINONE, MONOAZO AND STYRYL DYES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-02-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210115489-A1 NOVEL MEDIATOR MPO, EPX, LPO KMT2A 3104/4885MEN1 2351/4885MAPT 4015/4885
US-20230310294-A1 COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS COMPOSITION KRT18, KAT2B, SPIN2B KMT2A 516/4885MEN1 4618/4885MAPT 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.